County Tipperary, Ireland

Orlaith Ryan

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Orlaith Ryan: Innovating Cancer Treatment in County Tipperary**

Introduction

Orlaith Ryan, an accomplished inventor based in County Tipperary, Ireland, has made significant strides in the field of pharmaceuticals. With a keen focus on developing effective cancer treatments, her inventive work exemplifies the intersection of innovation and medical research.

Latest Patents

Ryan holds a notable patent for "Stable formulations comprising thiotepa." This patent outlines pharmaceutical compositions that incorporate thiotepa along with polyethylene glycol (such as PEG400 or PEG600) and dimethyl sulfoxide (DMSO), optionally including water or saline solutions and thiosulfate. The innovation is characterized by its purity, being free or substantially free of impurities, making it a valuable asset in the field. Additionally, the patent encompasses methods for treating cancer and facilitating myeloablation prior to bone marrow transplantation using the formulated composition. It also considers enhancing the stability of thiotepa formulations, thus promising improved efficacy in cancer therapies.

Career Highlights

Orlaith Ryan is currently associated with Shorla Pharma Limited, where she leverages her expertise in pharmaceutical formulations to drive advancements in cancer treatment. Her contribution to the field has been instrumental in developing new therapeutic strategies that can significantly impact patient outcomes.

Collaborations

At Shorla Pharma Limited, Ryan collaborates with talented professionals, including her colleagues Sharon Cunningham and Johannes Jan Platteeuw. Together, they contribute to an innovative environment that fosters the development of cutting-edge pharmaceutical solutions aimed at improving healthcare.

Conclusion

Orlaith Ryan's work exemplifies how innovation in pharmaceuticals can play a critical role in addressing complex health challenges, such as cancer. Her patent for stable thiotepa formulations represents not only a scientific achievement but also a step forward in enhancing treatment options for patients. As her career progresses, Ryan continues to inspire others in the field of medical research and product development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…